netFormulary
 Report : A-Z HCD items in Formulary 18/09/2019 01:55:56
[Back]
 
Section Status CCG Name
10.01.03 Restricted Use CCG Brodalumab Kyntheum
08.01.05 Formulary CCG Dupilumab 
06.01.02.03 Formulary CCG Ertugliflozin  Steglatro
10.01.03 Restricted Use CCG Golimumab Simponi
13.05.03 Formulary CCG Guselkumab Tremfya
13.05.03 Formulary CCG Ixekizumab Taltz
03.03.03 Formulary CCG Roflumilast Daxas
13.05.03 Formulary CCG Tildrakizumab 
01.05.03 Formulary CCG Tofacitinib Xeljanz
10.02.01 Formulary CCG Tofacitinib Xeljanz
Birmingham, Sandwell, Solihull and environs APC Formulary